Search
Now showing items 1-10 of 11
Coronary slow flow: a potential prognostic marker correlating with the disease severity in renal failure?
(OXFORD UNIV PRESS, 2010)
…
Superiority of levosimendan over dobutamine in right ventricle failure
(LIPPINCOTT WILLIAMS & WILKINS, 2010)
…
Geodesic pattern of coronary arteries as a predictor for cardiovascular risk: Clinical perspectives
(ELSEVIER IRELAND LTD, 2010)
Coronary angiography, despite current shortcomings, has been regarded as golden standard for the assessment of coronary arteries. Geodesic pattern of coronary arteries characterized by curvature, torsion and tortuosity ...
Free-floating biatrial thrombi with concomitant saddle pulmonary embolism
(ELSEVIER IRELAND LTD, 2010)
Free-floating intracardiac thrombi represent a severe yet uncommon condition and mostly coexist with thromboembolism. Notably, mobile right heart thrombus can occur in patients with massive pulmonary embolism. Early diagnosis ...
Efficacy of levosimendan in patients with chronic heart failure: Does rhythm matter?
(AVES YAYINCILIK, 2010)
Objective: Leyosimendan is a relatively new inotropic agent. Unlike other inotropic agents, Levosimendan does not increase cellular calcium intake, so that, does not cause intracellular calcium overload and related ...
Acute Effects of Levosimendan and Dobutamine on QRS Duration in Patients with Heart Failure
(ARQUIVOS BRASILEIROS CARDIOLOGIA, 2010)
Background: Levosimendan is a novel inotropic agent that enhances cardiac contractility without increasing cellular calcium intake, so that it is not supposed to cause intracellular calcium overload and related arrhythmias. ...
Genetic basis of sudden cardiac death due to emotional trauma in apparently healthy individuals
(ELSEVIER IRELAND LTD, 2010)
…
